Voters oppose more stringent IP protections – patent settlement polling proves
AAM 2019
[Association for Accessible Medicines, “National Survey Finds Significant Voter Opposition to Patent Settlement Legislation”, ]
WASHINGTON, DC (July 2, 2019) — A recent national survey finds by a margin of 4-1 that registered voters believe that patent settlement legislation will result in higher drug prices.
The generic industry opposes proposed legislation, as it would make it significantly more difficult to challenge patents that protect brand-name drugs from generic competition, a sentiment that voters agree with by a margin of 64%-36%.
In the end, a majority of voters (59%) oppose patent settlement legislation.
“This survey demonstrates that, in addition to being bad public policy that will result in higher drug prices, it is also bad politics,” said Scott Siff of Quadrant Strategies. “Drug prices are a critical issue going into this election year, and legislation that will result in higher drug prices will be poisonous for candidates.”